| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 653870 | 67577 | LANSOPRAZOL QUALIGEN 30 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL QUALIGEN 30 mg CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67577/67577_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67577/67577_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2006-02-21 | 1 | 1 | 1 | 2006-02-21 | 2006-02-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 654651 | 45303 | ELIXIFILIN 5,33 MG/ML SOLUCION ORAL | ELIXIFILIN 5,33 MG/ML SOLUCION ORAL, 1 frasco de 250 ml | 27 mg/5 ml | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/45303/45303_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/45303/45303_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 67885 | TORA LABORATORIES S.L.U. | 1967-12-01 | 1 | 1 | 1 | 1967-12-01 | 2012-11-12 | 1 | 2013-01-03 | 655563 | View Edit Delete | |||||||||||
| 653404 | 65956 | IBUPROFENO ALDO-UNIÓN 20 mg/ml SUSPENSIÓN ORAL EFG | IBUPROFENO ALDO-UNIÓN 20 mg/ml SUSPENSIÓN ORAL EFG, 1 frasco de 200 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65956/65956_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65956/65956_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2004-03-09 | 1 | 1 | 1 | 2004-03-09 | 2006-09-14 | 1 | 2011-07-14 | 835439 | View Edit Delete | |||||||||||
| 653544 | 57593 | TOBREX UNGÜENTO OFTÁLMICO 3 MG/G POMADA OFTÁLMICA | TOBREX UNGÜENTO OFTÁLMICO 3 MG/G POMADA OFTÁLMICA , 1 tubo de 3,5 g | 3 mg/g | 10 | 3,5 | 21 | 1 tubo de 3,5 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57593/57593_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57593/57593_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1988-04-01 | 1 | 1 | 1 | 1988-04-01 | 2012-04-17 | 0 | 2013-01-03 | 977306, 653223, 656833 | View Edit Delete | |||||||||||
| 654187 | 35403 | ADRENALINA LEVEL 1mg/ml SOLUCION INYECTABLE JERINGA PRECARGADA | ADRENALINA LEVEL 1mg/ml SOLUCION INYECTABLE JERINGA PRECARGADA, 1 jeringa precargada de 1 ml | 1 mg | 33 | 1 | 61 | 1 jeringa precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/35403/35403_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/35403/35403_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1961-02-01 | 1 | 1 | 1 | 1961-02-01 | 2012-05-16 | 1 | 2013-01-03 | 881466, 686444, 999801, 656722, 656956 | View Edit Delete | |||||||||||
| 654443 | 09590002 | PREVENAR 13 SUSPENSION INYECTABLE | PREVENAR 13 SUSPENSION INYECTABLE, 1 jeringa precargada de 0,5 ml + 1 AGUJAS | N/A (vacuna) | 33 | 1 | 61 | 1 jeringa precargada de 0,5 ml + 1 AGUJAS | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09590002/09590002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09590002/09590002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2009-12-29 | 1 | 1 | 1 | 2009-12-29 | 2012-07-17 | 1 | 2023-11-06 | 664470 | View Edit Delete | |||||||||||
| 653296 | 55845 | PROCTOSTEROID 10 MG ESPUMA RECTAL | PROCTOSTEROID 10 MG ESPUMA RECTAL 1 envase a presión de 20 g | 10 mg/g | 34 | 20 | 21 | 1 envase a presión de 20 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/55845/55845_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/55845/55845_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 1984-04-01 | 1 | 1 | 1 | 1984-04-01 | 2011-10-26 | 1 | 2012-01-02 | 671651, 999876, 656659 | View Edit Delete | |||||||||||
| 653627 | 29243 | CAOSINA 1.000 MG POLVO PARA SUSPENSIÓN ORAL. | CAOSINA 1.000 MG POLVO PARA SUSPENSIÓN ORAL. , 24 sobres | 2.500 mg (1.000 mg Ca) | 35 | 24 | 64 | 24 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/29243/29243_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/29243/29243_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1958-05-01 | 1 | 1 | 1 | 1958-05-01 | 2011-11-29 | 1 | 2012-01-02 | 698985, 685891, 820092, 656796 | View Edit Delete | |||||||||||
| 654571 | 67875 | ASPIRINA 500 mg GRANULADO | ASPIRINA 500 mg GRANULADO , 10 sobres | 500 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67875/67875_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67875/67875_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2006-06-19 | 1 | 1 | 1 | 2006-06-19 | 2006-06-19 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 654057 | 67650 | UBTEST 100 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA | UBTEST 100 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA , 1 comprimido | 100 mg | 35 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67650/67650_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67650/67650_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | FERRER FARMA S.A. | 2006-03-28 | 1 | 1 | 1 | 2006-03-28 | 2006-03-28 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 654666 | 67916 | IBUPROFENO KERN PHARMA 200 mg GRANULADO EFERVESCENTE EFG | IBUPROFENO KERN PHARMA 200 mg GRANULADO EFERVESCENTE EFG , 20 sobres | 200 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67916/67916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67916/67916_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-07-04 | 1 | 1 | 1 | 2006-07-04 | 2006-07-04 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 653049 | 71209 | NITROFIX 5 mg PARCHES TRANSDERMICOS EFG | NITROFIX 5 mg PARCHES TRANSDERMICOS EFG, 30 parches | 5 mg/24 h | 35 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71209/71209_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71209/71209_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2009-07-17 | 1 | 1 | 1 | 2009-07-17 | 2011-10-28 | 1 | 2014-05-01 | 663673, 672041 | View Edit Delete | |||||||||||
| 653056 | 71214 | NITROFIX 15 mg PARCHES TRANSDERMICOS EFG | NITROFIX 15 mg PARCHES TRANSDERMICOS EFG, 30 parches | 15 mg/24 h | 35 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71214/71214_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71214/71214_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2009-07-17 | 1 | 1 | 1 | 2009-07-17 | 2011-10-28 | 1 | 2011-11-28 | 663676, 672040 | View Edit Delete | |||||||||||
| 653064 | 71210 | NITROFIX 10 mg PARCHES TRANSDERMICOS EFG | NITROFIX 10 mg PARCHES TRANSDERMICOS EFG, 30 parches | 10 mg/24 h | 35 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71210/71210_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71210/71210_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2009-07-17 | 1 | 1 | 1 | 2009-07-17 | 2011-10-28 | 1 | 2011-11-28 | 663678, 672037 | View Edit Delete | |||||||||||
| 653406 | 65640 | ARATRO 500 mg POLVO PARA SUSPENSION ORAL EN SOBRE EFG | ARATRO 500 mg POLVO PARA SUSPENSION ORAL EN SOBRE EFG, 3 sobres | 500 mg | 35 | 3 | 64 | 3 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65640/65640_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65640/65640_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2003-09-26 | 1 | 1 | 1 | 2003-09-26 | 2006-09-26 | 1 | 2011-11-28 | 731430 | View Edit Delete | |||||||||||
| 653193 | 65753 | AZITROMICINA ALTER 500 mg GRANULADO PARA SUSPENSION ORAL EFG | AZITROMICINA ALTER 500 mg GRANULADO PARA SUSPENSION ORAL EFG, 3 sobres | 500 mg | 35 | 3 | 64 | 3 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65753/65753_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65753/65753_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2003-10-31 | 1 | 1 | 1 | 2003-10-31 | 2006-04-06 | 1 | 2011-11-11 | 764613 | View Edit Delete | |||||||||||
| 653935 | 05331002 | NEUPRO 2 MG/24 H PARCHE TRANSDERMICO | NEUPRO 2 MG/24 H PARCHE TRANSDERMICO, 28 parches | 2 mg/24 h | 35 | 28 | 28 | 28 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05331002/05331002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05331002/05331002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | UCB PHARMA S.A. | 2006-04-21 | 1 | 1 | 1 | 2006-04-21 | 2006-04-21 | 1 | 2011-03-31 | View Edit Delete | ||||||||||||
| 653937 | 05331005 | NEUPRO 4 MG/24 H PARCHE TRANSDERMICO | NEUPRO 4 MG/24 H PARCHE TRANSDERMICO, 28 parches | 4 mg/24 h | 35 | 28 | 28 | 28 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05331005/05331005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05331005/05331005_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | UCB PHARMA S.A. | 2006-04-21 | 1 | 1 | 1 | 2006-04-21 | 2006-04-21 | 1 | 2011-03-31 | View Edit Delete | ||||||||||||
| 653939 | 05331008 | NEUPRO 6 MG/24 H PARCHE TRANSDERMICO | NEUPRO 6 MG/24 H PARCHE TRANSDERMICO, 28 parches | 6 mg/24 h | 35 | 28 | 28 | 28 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05331008/05331008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05331008/05331008_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | UCB PHARMA S.A. | 2006-04-21 | 1 | 1 | 1 | 2006-04-21 | 2006-04-21 | 1 | 2011-03-31 | View Edit Delete | ||||||||||||
| 653941 | 05331011 | NEUPRO 8 MG/24 H PARCHE TRANSDERMICO | NEUPRO 8 MG/24 H PARCHE TRANSDERMICO, 28 parches | 8 mg/24 h | 35 | 28 | 28 | 28 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05331011/05331011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05331011/05331011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | UCB PHARMA S.A. | 2006-04-21 | 1 | 1 | 1 | 2006-04-21 | 2006-04-21 | 1 | 2011-03-31 | View Edit Delete |
Page 72 of 1036, showing 20 records out of 20704 total, starting on record 1421, ending on 1440